Workflow
百元股
icon
Search documents
古井贡酒跌2.01%,成交额1.59亿元,主力资金净流出1474.24万元
Xin Lang Cai Jing· 2026-01-21 02:27
Core Viewpoint - Gujinggong Liquor's stock has experienced a decline, with a 2.01% drop on January 21, 2025, and a total market value of 68.655 billion yuan. The company has seen a significant decrease in stock price over various time frames, indicating potential challenges in its financial performance and market perception [1]. Financial Performance - For the period from January to September 2025, Gujinggong Liquor reported a revenue of 16.425 billion yuan, a year-on-year decrease of 13.87%. The net profit attributable to shareholders was 3.960 billion yuan, down 16.57% compared to the previous year [2]. - Cumulatively, since its A-share listing, Gujinggong Liquor has distributed a total of 12.612 billion yuan in dividends, with 7.136 billion yuan distributed over the last three years [3]. Shareholder Information - As of January 9, 2025, the number of shareholders for Gujinggong Liquor was 53,000, reflecting a decrease of 0.28% from the previous period. The average circulating shares per person remained at 0 [2]. - The top ten circulating shareholders include significant institutional investors, with notable changes in holdings. For instance, the second-largest shareholder, China Securities White Wine Index A, increased its holdings by 2.3527 million shares, while E Fund Consumer Industry Stock reduced its holdings by 191,900 shares [3].
云汉芯城涨2.02%,成交额1.72亿元,主力资金净流入482.60万元
Xin Lang Cai Jing· 2026-01-20 03:12
Group 1 - The core viewpoint of the news is that Yunhan Chip City has shown significant stock performance with a year-to-date increase of 17.23% and a recent rise of 4.87% over the last five trading days [1] - As of January 20, the stock price reached 179.66 yuan per share, with a total market capitalization of 11.699 billion yuan [1] - The company has experienced notable trading activity, with a net inflow of 4.826 million yuan from major funds and significant trading volumes on the stock exchange [1] Group 2 - Yunhan Chip City, established on May 7, 2008, is located in Shanghai and specializes in providing a one-stop supply chain service for electronic components through its B2B online mall [2] - The company's main business revenue composition includes 56.14% from semiconductor devices, 17.35% from connectors, 16.05% from passive components, and 10.19% from other sources [2] - For the period from January to September 2025, Yunhan Chip City achieved an operating income of 2.229 billion yuan, representing a year-on-year growth of 20.68%, and a net profit attributable to shareholders of 81.4604 million yuan, up 46.74% year-on-year [2]
3股今日首次突破百元 最新百元股数量达222只
Market Overview - The average stock price in A-shares is 14.69 yuan, with 222 stocks priced over 100 yuan, an increase of 5 stocks from the previous trading day [1] - The Shanghai Composite Index closed at 4114.00 points, up 0.29%, while stocks priced over 100 yuan had an average decline of 0.08%, underperforming the index by 0.38 percentage points [1] - In the past month, stocks priced over 100 yuan have seen an average increase of 22.00%, compared to a 6.13% rise in the Shanghai Composite Index [1] High-Value Stocks - The highest closing price among stocks over 100 yuan is 1419.66 yuan for Cambrian, followed by Kweichow Moutai at 1376.00 yuan and Source Technology at 748.29 yuan [1] - Among the stocks that crossed the 100 yuan mark today, New Spring Co. closed at 103.71 yuan, up 3.95%, with a turnover rate of 6.00% and a net inflow of 2.11 billion yuan [2] - Other notable stocks include Aobi Zhongguang at 102.46 yuan, up 4.23%, and Jinpan Technology at 106.24 yuan, up 8.43% [2] Industry Distribution - The electronic industry has the highest concentration among stocks priced over 100 yuan, with 79 stocks, accounting for 35.59% of the total [2] - The mechanical equipment industry has 26 stocks, making up 11.71%, while the computer industry has 24 stocks, representing 10.81% [2] - In terms of market segments, there are 45 stocks from the main board, 72 from the ChiNext board, 5 from the Beijing Stock Exchange, and 100 from the Sci-Tech Innovation Board, with the latter accounting for 45.05% of the high-value stocks [2] Institutional Ratings - Four stocks priced over 100 yuan received "buy" ratings from institutions today, including WuXi AppTec, SiYuan Electric, and Shenghong Technology [2]
222只!百元股数量创历史新高,科技新贵扎堆
Jin Rong Jie· 2026-01-19 08:15
Core Viewpoint - The A-share market has reached a historical high with 222 stocks closing above 100 yuan, indicating a significant trend in high-value stocks [1] Group 1: Stock Performance - The stock with the highest closing price is Cambrian Technology-U at over 1400 yuan, followed by Kweichow Moutai at 1376 yuan and Source Code Technology at 748.29 yuan [1] - Several stocks, including Moore Threads-U, Zhongji Xuchuang, Guodun Quantum, and Muxi Co., have also surpassed 500 yuan in closing price [1] Group 2: Sector Analysis - The majority of the top ten stocks by closing price are technology companies, with Kweichow Moutai being the only exception not in the tech sector [1]
北方长龙跌2.01%,成交额1.27亿元,主力资金净流出2143.34万元
Xin Lang Cai Jing· 2026-01-16 02:08
Group 1 - The stock price of Beifang Changlong has decreased by 2.01% to 143.63 CNY per share, with a trading volume of 1.27 billion CNY and a market capitalization of 13.674 billion CNY [1] - Year-to-date, Beifang Changlong's stock has increased by 1.89%, but it has dropped by 6.61% over the last five trading days [2] - The company specializes in the research, design, production, and sales of non-metal composite materials for military vehicle applications, with 70% of its revenue coming from human-machine interface systems for military vehicles [2] Group 2 - As of December 31, the number of shareholders for Beifang Changlong is 27,600, a decrease of 0.50% from the previous period [2] - For the period from January to September 2025, Beifang Changlong achieved a revenue of 122 million CNY, representing a year-on-year growth of 159.21%, and a net profit of 11.2885 million CNY, up by 208.52% [2] - The company has distributed a total of 43.384 million CNY in dividends since its A-share listing [3]
江波龙涨2.01%,成交额12.84亿元,主力资金净流出2090.34万元
Xin Lang Zheng Quan· 2026-01-16 01:55
Core Viewpoint - Jiangbolong's stock has shown significant growth in 2023, with a year-to-date increase of 29.78% and a 75.64% rise over the past 60 days, indicating strong market performance and investor interest [1]. Financial Performance - For the period from January to September 2025, Jiangbolong achieved a revenue of 16.734 billion yuan, representing a year-on-year growth of 26.12% [2]. - The net profit attributable to shareholders for the same period was 713 million yuan, reflecting a year-on-year increase of 27.95% [2]. Shareholder Information - As of September 30, 2025, the number of shareholders for Jiangbolong reached 43,800, an increase of 25.06% compared to the previous period [2]. - The average number of circulating shares per shareholder decreased by 20.04% to 6,260 shares [2]. Dividend Distribution - Since its A-share listing, Jiangbolong has distributed a total of 302 million yuan in dividends, with 104 million yuan distributed over the past three years [3]. Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the eighth largest circulating shareholder, holding 6.1139 million shares, an increase of 4.8541 million shares from the previous period [3]. - Several funds, including E Fund's ChiNext ETF and others, have exited the list of the top ten circulating shareholders [3].
艾力斯跌2.01%,成交额3.57亿元,主力资金净流出1483.23万元
Xin Lang Cai Jing· 2026-01-15 06:22
Core Viewpoint - The stock price of Ailis has experienced a decline of 3.84% year-to-date, with a notable drop of 3.89% over the last five trading days, indicating a bearish trend in the market [2]. Company Overview - Ailis Pharmaceutical Technology Co., Ltd. was established on March 22, 2004, and went public on December 2, 2020. The company is primarily engaged in the research, production, and sales of innovative drugs [2]. - The main revenue source for Ailis is drug sales, accounting for 99.93% of total revenue, with promotional services contributing 0.06% and other sources at 0.00% [2]. Financial Performance - For the period from January to September 2025, Ailis reported a revenue of 3.733 billion yuan, representing a year-on-year growth of 47.35%. The net profit attributable to shareholders was 1.616 billion yuan, reflecting a 52.01% increase compared to the previous year [2]. - Since its A-share listing, Ailis has distributed a total of 653 million yuan in dividends [3]. Shareholder and Market Activity - As of September 30, 2025, the number of Ailis shareholders increased by 46.82% to 19,100, while the average circulating shares per person decreased by 31.89% to 23,551 shares [2]. - The stock's trading activity showed a net outflow of 14.83 million yuan from main funds, with significant buying and selling activity from large orders [1].
艾力斯跌2.07%,成交额3.30亿元,主力资金净流出2359.09万元
Xin Lang Cai Jing· 2026-01-14 05:33
Core Viewpoint - The stock price of Ailis has experienced fluctuations, with a recent decline of 1.47% year-to-date and a 5.33% drop over the last five trading days, indicating potential volatility in the market [2]. Group 1: Stock Performance - As of January 14, Ailis's stock price decreased by 2.07%, trading at 102.62 CNY per share, with a total market capitalization of 46.179 billion CNY [1]. - Year-to-date, Ailis's stock has dropped by 1.47%, while it has seen a 5.33% decline over the past five trading days [2]. - Over the last 20 days, the stock has increased by 1.48%, but it has decreased by 0.71% over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Ailis reported a revenue of 3.733 billion CNY, reflecting a year-on-year growth of 47.35%, and a net profit attributable to shareholders of 1.616 billion CNY, which is a 52.01% increase [2]. - The company has distributed a total of 653 million CNY in dividends since its A-share listing [3]. Group 3: Shareholder and Institutional Holdings - As of September 30, 2025, Ailis had 19,100 shareholders, an increase of 46.82% from the previous period, with an average of 23,551 circulating shares per shareholder, down by 31.89% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 20.9471 million shares, an increase of 10.5693 million shares from the previous period [3]. - Other notable institutional shareholders include China Europe Medical Health Mixed A and E Fund Shanghai Stock Exchange Sci-Tech Innovation Board 50 ETF, with varying changes in their holdings [3].
欧陆通涨2.06%,成交额6.11亿元,主力资金净流出709.82万元
Xin Lang Zheng Quan· 2026-01-14 03:21
Core Viewpoint - The stock price of Oulutong has shown a positive trend with a year-to-date increase of 6.72%, despite a slight decline of 1.32% over the past five trading days [2]. Group 1: Stock Performance - As of January 14, Oulutong's stock price rose by 2.06% to 235.86 CNY per share, with a trading volume of 611 million CNY and a turnover rate of 2.41%, resulting in a total market capitalization of 25.911 billion CNY [1]. - The stock has experienced a 14.00% increase over the past 20 days and a 26.74% increase over the past 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Oulutong achieved a revenue of 3.387 billion CNY, representing a year-on-year growth of 27.16%, and a net profit attributable to shareholders of 222 million CNY, reflecting a growth of 41.53% [2]. - Since its A-share listing, Oulutong has distributed a total of 229 million CNY in dividends, with 183 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of Oulutong shareholders reached 21,600, an increase of 25.48% from the previous period, with an average of 5,097 circulating shares per shareholder, a decrease of 18.27% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third-largest shareholder with 2.4112 million shares, an increase of 1.7864 million shares from the previous period [3].
百元股数量达216只,电子、计算机、机械设备行业占比均超10%
Core Viewpoint - The average stock price of A-shares is 14.69 yuan, with 216 stocks priced over 100 yuan, indicating a slight decrease in high-priced stocks compared to the previous trading day [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4138.76 points, down 0.64%, while stocks priced over 100 yuan saw an average decline of 2.13%, underperforming the index by 1.49 percentage points [1]. - In the past month, stocks priced over 100 yuan have averaged a 16.26% increase, significantly outperforming the Shanghai Composite Index, which rose by 6.41% [1]. Group 2: Stock Distribution - Among the stocks priced over 100 yuan, the electronics sector is the most represented with 76 stocks, accounting for 35.19% of the total, followed by the computer sector with 25 stocks (11.57%) and machinery equipment with 23 stocks (10.65%) [2]. - In terms of market segments, there are 45 stocks from the main board, 71 from the ChiNext, 6 from the Beijing Stock Exchange, and 94 from the Sci-Tech Innovation Board, with the latter making up 43.52% of the high-priced stocks [2]. Group 3: Institutional Ratings - Three stocks priced over 100 yuan received buy ratings from institutions, including Yaxin Integration, Yilian Technology, and Robot Technology, with the latter two being newly covered by institutions [2]. - Among the stocks with buy ratings, two have projected price targets that indicate an upside potential exceeding 20%, with Yaxin Integration having the highest potential increase of 29.04% [2].